- January 17, 2017Diptheria-Pertussis-Tetanus vaccine participation among Indian children, study identifies major influences
Parents’ education and healthcare access affect diphtheria-pertussis-tetanus (DPT) vaccine uptake among children in India.
Read moreRead more Read More - October 13, 2015Microbiology culture market estimated to attain revenues worth US $7.5 bn by 2023.
Transparency Market Research – October 13, 2015. “According to the Centre for Disease Dynamics, Economics and Policy (CDDEP), a U.S.-based independent research body, the demand for antibiotics will soar to 105.600 tons by 2030, to cater to the healthcare needs of about 8.5 bn people. From infection control to better agricultural productivity to improving industrial […]
Read moreRead more Read More - April 9, 2015Living on Earth: Growth In Livestock Antibiotics Raises Risks For Humans
How exactly does globally increasing livestock antibiotic use adversely affect human health?
Read moreRead more Read More
CDDEP Director Ramanan Laxminarayan was interviewed on PRI's Living On Earth radio program to examine this question. Laxminarayan addresses how and when … - July 9, 2014Global Antibiotic Consumption Soars 36% in 10 years, Raising Concerns About Superbugs
WASHINGTON, D.C. – Human consumption of antibiotics around the globe increased by 36% in the 2000-2010 period, primarily in the developing world, raising concerns about the threat of antimicrobial resistance, according to a study by researchers from …
Read moreRead more Read More - April 22, 2014Managed Care Features CDDEP’s Drug Resistance Index
CDDEP's Drug Resistance Index (DRI), which aggregates bacterial resistance to various drugs, was featured in this month's issue of Managed Care. The DRI was developed by CDDEP Director Ramanan Laxminarayan and former Emory University …
Read moreRead more Read More - October 25, 2013‘Hunting the Nightmare Bacteria’ Features CDDEP Director Ramanan Laxminarayan
A new PBS Frontline documentary Hunting the Nightmare Bacteria brings to light the reach and magnitude of antibiotic resistance. Through first-hand accounts tracking personal brushes with so-called superbugs bacteria resistant to most known …
Read moreRead more Read More - August 8, 2013Fast Company Blogs About Resistance, CDDEP research
This week, a blog run by Fast Company called Co.Exist, which focuses on “world-changing ideas and information,” posted a writeup on a concept that is central to CDDEP's Extending the Cure (ETC) project: antibiotic effectiveness should be treated …
Read moreRead more Read More - July 24, 2013Studies Calculate Costs of Medical Services in Indian Hospitals
NEW DELHI (July 24, 2013) – A new study appearing in PLOS ONE, by researchers from the Center for Disease Dynamics, Economics & Policy (CDDEP), takes a groundbreaking look at the cost of health care from an operational standpoint. It is a …
Read moreRead more Read More - April 4, 2013CDDEP Director Ramanan Laxminarayan Discusses India’s Antibiotic Use Policy on CNN-IBN
India's Ministry of Health is considering a new label for antibiotics and other pharmaceutical products that would warn consumers about the risks of over-the-counter drug use. CDDEP Director Dr. Ramanan Laxminarayan appeared on CNN-IBN's …
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.